Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function
Alzheimer’s disease (AD) is a neurodegenerative disorder, comprising 70% of dementia diagnoses worldwide and affecting 1 in 9 people over the age of 65. However, the majority of its treatments, which predominantly target the cholinergic system, remain insufficient at reversing pathology and act simp...
Main Authors: | Grace Cunliffe, Yi Tang Lim, Woori Chae, Sangyong Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/12/3064 |
Similar Items
-
Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases
by: Xin Yi Yeo, et al.
Published: (2022-02-01) -
A Procedural Overview of the Involvement of Small Molecules in the Nervous System in the Regulation of Bone Healing
by: Wei X, et al.
Published: (2025-01-01) -
Serum and Oral Fluid Levels of Protein Markers and Hormones in Patients With Alcohol Dependence Syndrome
by: G. A. Ermakova, et al.
Published: (2024-11-01) -
NPY family of peptides in neurobiology, cardiovascular and metabolic disorders : from genes to therapeutics /
by: Zukowska, Zofia, et al.
Published: (2006) -
Transcranial focused ultrasound precise neuromodulation: a review of focal size regulation, treatment efficiency and mechanisms
by: Jie Jin, et al.
Published: (2024-09-01)